Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by Sandman852on Jan 16, 2020 9:49am
127 Views
Post# 30559816

RE:RE:RE:RE:RE:Crazy Volume

RE:RE:RE:RE:RE:Crazy Volume     Just want to point out a couple of things.  First production of the first units will be in march so likely some investors are waiting / slowly adding on dips 
      Secondly the big recurring revenue - which is key to sustainability is in the cartridges/ filters which are only good for one use and have a 40 dollar (approx) NET profit margin. Therefore getting the product in lots of sectors should be ramped up through a large medical distribution company while retaining all the cartridge revenue to build growing  cash flow and profit for the future 
        We should hear some positive news in the next 3-4 weeks once we are closer to the production rollout 
<< Previous
Bullboard Posts
Next >>